Patent: 7,727,558
✉ Email this page to a colleague
Summary for Patent: 7,727,558
Title: | Polymeric delivery agents and delivery agent compounds |
Abstract: | Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well. |
Inventor(s): | Milstein; Sam J. (Larchmont, NY), Barantsevitch; Eugene N. (Scarsdale, NY), Wang; Nai Fang (Long Island City, NY), Liao; Jun (Yorktown Heights, NY), Smart; John (Katonah, NY), Conticello; Richard (Ossining, NY), Ottenbrite; Raphael (Midlothian, VA) |
Assignee: | Emisphere Technologies, Inc. (Tarrytown, NY) Virginia Commonwealth University (Richmond, VA) |
Application Number: | 11/669,649 |
Patent Claims: | see list of patent claims |
Details for Patent 7,727,558
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 10/28/1982 | ⤷ Try a Trial | 2019-01-08 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 12/29/2015 | ⤷ Try a Trial | 2019-01-08 |
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 08/06/1998 | ⤷ Try a Trial | 2019-01-08 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 03/31/1994 | ⤷ Try a Trial | 2019-01-08 |
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 05/25/2018 | ⤷ Try a Trial | 2019-01-08 |
Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 02/20/1991 | ⤷ Try a Trial | 2019-01-08 |
Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 06/28/2000 | ⤷ Try a Trial | 2019-01-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |